Emergent Biosolutions Inc (EBS)

Operating Expenses

$262.30M

Quarterly · Period ending: · USD

EBS logo

EBS Operating Expenses

Latest reported$262.30M
EBS Quarterly Operating Expenses ($228.50M → $262.30M)
High-resolution chart · PNG

EBS operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Emergent Biosolutions Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
262,300,000
57,100,000
63,200,000
52,300,000
57,000,000
67,900,000
146,000,000
99,700,000
138,000,000
101,000,000
213,000,000
334,500,000
416,300,000
123,300,000
169,600,000
96,400,000
94,800,000
99,300,000
150,200,000
97,500,000
106,300,000
96,900,000
97,500,000
119,500,000
91,000,000
85,100,000
125,700,000
79,700,000
85,500,000
79,900,000
97,100,000
46,000,000
43,400,000
43,900,000
56,429,000
35,403,000
32,068,000
35,550,000
35,358,000
40,688,000
35,924,999
32,513,000
44,709,000
25,800,000
24,670,000
35,793,000
31,905,000
30,292,000
30,555,000
30,501,000
26,134,000
21,897,000
20,483,000
20,011,000
16,245,999
19,171,000
48,540,000
45,738,000
47,630,000
46,648,000
51,865,000
52,971,000
51,286,000
41,849,000
36,251,000
36,114,000
37,897,000
38,539,000
40,053,000
31,885,000
28,026,000
30,742,000
32,245,000
23,535,000
28,935,000
27,815,000
26,001,000
26,763,000
30,510,000
19,864,000
0
0
-82,777,000
0
0
0
-70,542,000
0
0
0
228,500,000
363,700,000
495,900,000
301,100,000
228,500,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.